Scored drug-market and company safety briefs from openFDA, FDA and BLS: drug recalls, adverse event reports, label changes and approvals for the US drug market and for Pfizer, Eli Lilly and Johnson & Johnson, clinical-trial pipelines (ClinicalTrials.gov), drug shortages, medical device recalls and adverse events, FDA warning letters, and drug price inflation (CPI and PPI). Each brief is a 0-100 score with label, trend, drivers, risk flags, confidence and citations. POST /v1/brief {vertical, entity_id} returns one scored brief; POST /v1/overview returns every brief at once; POST /v1/verticals lists them. Verticals: drug-market (Are drug safety signals rising, and is the approval pipeline active?); company-safety (Are safety signals rising for this drug maker, and what has the FDA reported lately?); clinical-pipeline (Is this drug maker's trial pipeline growing or stalling?); drug-shortages (Are drug shortages and discontinuations rising in the US?); device-safety (Are medical device recalls and adverse event reports rising?); drug-prices (Are prescription drug prices rising faster than usual?); fda-enforcement (Is the FDA issuing more warning letters than usual?). Raw scored series: /v1/signals, /v1/signal, /v1/explain, /v1/catalog, /v1/events. Every response is a single JSON object. Research signal, not investment advice.
